Literature DB >> 21943303

Is intensive multimodality therapy the best treatment for fournier gangrene? Evaluation of clinical outcome and survival rate of 41 patients.

Sigrid Wagner1, Francesco Greco, M Raschid Hoda, Felix Kawan, Hans Heynemann, Paolo Fornara.   

Abstract

BACKGROUND: To evaluate the effect of surgical wound debridement, antibiotics, and hyperbaric oxygen (HBO) in the treatment of Fournier gangrene (FG).
METHODS: Forty-one patients with a mean age of 54.3±14.6 years were referred to our department with a diagnosis of FG. To calculate a Fourier Gangrene Severity Index (FGSI), nine factors were assessed (temperature; heart rate; ventilatory rate; serum sodium, potassium, creatinine, and bicarbonate concentrations; hematocrit; and leukocyte count). After clinical stabilization, extensive debridement of the necrotic tissue was performed, and a surgical vacuum-assisted closure (V.A.C.®) device was applied. Hyperbaric oxygen was administered; medical therapy consisted of intravenous antibiotics, electrolyte replacement, and parenteral nutrition.
RESULTS: Intraoperative cultures revealed Escherichia coli in 27 patients (66%), Pseudomonas aeruginosa in 28 (68%), gram-positive cocci in 24 (59%), and mixed flora (aerobic and anaerobic bacteria) in 39 (95%). One month after primary debridement, wound granulation was sufficient for plastic surgical reconstruction in all patients.
CONCLUSION: Because of the rapid worsening of FG, early diagnosis and immediate, aggressive multi-modality therapy with surgical debridement and broad-spectrum empiric antibiotics is crucial. The utility of HBO remains unproved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21943303     DOI: 10.1089/sur.2010.091

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  2 in total

1.  Community-acquired, hospital-acquired, and healthcare-associated pneumonia caused by Pseudomonas aeruginosa.

Authors:  Ayumi Fujii; Masafumi Seki; Masachika Higashiguchi; Isao Tachibana; Atsushi Kumanogoh; Kazunori Tomono
Journal:  Respir Med Case Rep       Date:  2014-03-26

2.  Which Role for Hyperbaric Oxygen Therapy in the Treatment of Fournier's Gangrene? A Retrospective Study.

Authors:  Roberta Tutino; Francesco Colli; Giovanna Rizzo; Sebastiano Bonventre; Gregorio Scerrino; Giuseppe Salamone; Giuseppina Melfa; Giuseppina Orlando; Gaetano Gallo; Mauro Santarelli; Marco Massani; Gianfranco Cocorullo
Journal:  Front Surg       Date:  2022-04-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.